Hepatitis C in the United States.
作者信息
Holmberg Scott D, Spradling Philip R, Moorman Anne C, Denniston Maxine M
机构信息
Epidemiology and Surveillance Branch, Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, USA.
出版信息
N Engl J Med. 2013 May 16;368(20):1859-61. doi: 10.1056/NEJMp1302973.
Abstract
摘要
相似文献
1
Hepatitis C in the United States.美国的丙型肝炎
N Engl J Med. 2013 May 16;368(20):1859-61. doi: 10.1056/NEJMp1302973.
2
Chronic Hepatitis C Infection in Children.儿童慢性丙型肝炎感染
Adv Pediatr. 2016 Aug;63(1):173-94. doi: 10.1016/j.yapd.2016.04.019.
3
[Treatment of chronic hepatitis C].[慢性丙型肝炎的治疗]
Orv Hetil. 2004 May 16;145(20):1065-7.
4
[Hepatitis C in Egypt, a iatrogenic epidemic].[埃及的丙型肝炎，一场医源性流行病]
Ned Tijdschr Geneeskd. 2000 Dec 2;144(49):2378.
5
Highly sensitive hepatitis C virus RNA detection assays for decision of treatment (dis)continuation in patients with chronic hepatitis C.用于决定慢性丙型肝炎患者治疗（停）续的高灵敏度丙型肝炎病毒RNA检测方法
J Hepatol. 2005 Apr;42(4):605-6. doi: 10.1016/j.jhep.2004.08.026. Epub 2004 Nov 26.
6
Commentary: detection of low level viraemia in telaprevir-based triple therapy for hepatitis C virus.评论：基于替拉瑞韦的丙型肝炎病毒三联疗法中低水平病毒血症的检测
Aliment Pharmacol Ther. 2014 Mar;39(5):543-4. doi: 10.1111/apt.12610.
7
Commentary: detection of low level viraemia in telaprevir-based triple therapy for hepatitis C virus - authors' reply.评论：基于替拉瑞韦的丙型肝炎病毒三联疗法中低水平病毒血症的检测——作者回复
Aliment Pharmacol Ther. 2014 Mar;39(5):544-5. doi: 10.1111/apt.12642.
8
[Standard diagnostic and therapeutic approach to chronic hepatitis C virus (HCV) infection 22 - guidelines].[慢性丙型肝炎病毒（HCV）感染的标准诊断与治疗方法22 - 指南]
Klin Mikrobiol Infekc Lek. 2017 Mar;23(1):22-40.
9
Mexican consensus on the diagnosis and management of hepatitis C infection.墨西哥丙型肝炎感染诊断与管理共识
Ann Hepatol. 2015;14 Suppl 1:5-48.
10
Can we use the "C" word with confidence? Cure for chronic hepatitis C.我们能放心地使用“治愈”这个词吗？慢性丙型肝炎的治愈。
Gastroenterology. 2011 Mar;140(3):766-8. doi: 10.1053/j.gastro.2011.01.018. Epub 2011 Jan 21.
引用本文的文献
1
Hepatitis C Surveillance in the United States: Past, Present, and Future.美国丙型肝炎监测：过去、现在与未来
Public Health Rep. 2025 Aug 28:333549251351880. doi: 10.1177/00333549251351880.
2
Strategies and efforts in circumventing the emergence of antiviral resistance against conventional antivirals.规避传统抗病毒药物出现耐药性的策略与努力。
NPJ Antimicrob Resist. 2025 Jun 9;3(1):54. doi: 10.1038/s44259-025-00125-z.
3
Disparities in hepatitis C among people aged 12-59 with no history of injection drug use, United States, January 2013-March 2020.2013 年 1 月至 2020 年 3 月期间，美国无注射吸毒史的 12-59 岁人群中的丙型肝炎差异。
Liver Int. 2024 Dec;44(12):3250-3259. doi: 10.1111/liv.16108. Epub 2024 Sep 26.
4
Evolution of heart transplant donor characteristics in the 21 century: A United States single center's experience.21世纪心脏移植供体特征的演变：美国单中心的经验
World J Transplant. 2024 Sep 18;14(3):92721. doi: 10.5500/wjt.v14.i3.92721.
5
Risk Factors Associated With Unsuccessful Linkage to Outpatient Hepatitis C Care.与门诊丙型肝炎护理衔接失败相关的风险因素。
Cureus. 2024 Apr 15;16(4):e58313. doi: 10.7759/cureus.58313. eCollection 2024 Apr.
6
Machine learning prediction of hepatic steatosis using body composition parameters: A UK Biobank Study.利用身体成分参数进行机器学习预测肝脂肪变性：一项英国生物银行研究。
NPJ Aging. 2024 Jan 9;10(1):4. doi: 10.1038/s41514-023-00127-z.
7
Hepatitis C Cascades: Data to Inform Hepatitis C Elimination in the United States.丙型肝炎传播链：为美国消除丙型肝炎提供信息的数据。
Public Health Rep. 2023 Sep 5:333549231193508. doi: 10.1177/00333549231193508.
8
Transcriptome changes in stages of non-alcoholic fatty liver disease.非酒精性脂肪性肝病各阶段的转录组变化
World J Hepatol. 2022 Jul 27;14(7):1382-1397. doi: 10.4254/wjh.v14.i7.1382.
9
Hepatitis C virus: A critical approach to who really needs treatment.丙型肝炎病毒：关于真正需要治疗人群的关键探讨。
World J Hepatol. 2022 Jan 27;14(1):1-44. doi: 10.4254/wjh.v14.i1.1.
10
Sofosbuvir, a New Nucleotide Analogue, for the Treatment of Chronic Hepatitis C Infection.索磷布韦，一种新型核苷酸类似物，用于治疗慢性丙型肝炎感染。
J Pharm Technol. 2015 Feb;31(1):29-37. doi: 10.1177/8755122514548897. Epub 2014 Sep 4.
本文引用的文献
1
Baseline characteristics and mortality among people in care for chronic viral hepatitis: the chronic hepatitis cohort study.接受慢性病毒性肝炎治疗人群的基线特征和死亡率：慢性肝炎队列研究。
Clin Infect Dis. 2013 Jan;56(1):40-50. doi: 10.1093/cid/cis815. Epub 2012 Sep 18.
2
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.推荐意见：识别 1945 年至 1965 年期间出生人群的慢性丙型肝炎病毒感染。
MMWR Recomm Rep. 2012 Aug 17;61(RR-4):1-32.
3
Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence.在 120 万获得医疗服务的人群中，乙型肝炎和丙型肝炎病毒感染：与检测和感染流行率相关的因素。
Clin Infect Dis. 2012 Oct;55(8):1047-55. doi: 10.1093/cid/cis616. Epub 2012 Aug 8.
4
Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008.对丙型肝炎病毒检测呈阳性的个体的感染意识、丙型肝炎知识和医疗随访：2001-2008 年全国健康和营养调查。
Hepatology. 2012 Jun;55(6):1652-61. doi: 10.1002/hep.25556. Epub 2012 Apr 10.
5
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.1999年至2002年美国丙型肝炎病毒感染的流行情况。
Ann Intern Med. 2006 May 16;144(10):705-14. doi: 10.7326/0003-4819-144-10-200605160-00004.
Zotero 插件